| Montana Foot Clinic Pc | |
|
3419 Central Ave, Ste B, Billings, MT 59102-6647 | |
| (406) 245-0888 | |
| (406) 245-1322 |
| Full Name | Montana Foot Clinic Pc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 3419 Central Ave, Billings, Montana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093759748 | NPI | - | NPPES |
| 94500 | Other | MT | BLUE CROSS AND BLUE SHIEL |
| DA5411 | Other | MT | RAILROAD MEDICARE |
| 0390762 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| Provider Name | Mathias H Fettig |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1124099585 PECOS PAC ID: 6002808441 Enrollment ID: I20100915000208 |
News Archive
Routine prophylactic drainage offers no benefits to patients undergoing pancreatic resection, say researchers.
Tecomet Inc., a Genstar Capital portfolio company and precision contract manufacturer supporting the medical device and aerospace industries, announced today that it has completed the previously announced acquisition of Symmetry Medical's OEM Solutions business. This acquisition creates the largest orthopedic contract manufacturer in the world with 18 facilities located in five countries on three continents.
The Smart Card Alliance Identity Council will turn its attention to cybersecurity and healthcare identity in the upcoming year, the Council said today, while continuing its work to educate and make identity credentialing recommendations for corporate enterprise, healthcare, state and local governments, and more. The Identity Council also announced new officers and steering committee, and plans to attend the Smart Card Alliance 8th Annual Smart Cards in Government Conference in Washington, DC.
AMRI announced today that on-going results from its Phase I clinical study on its novel tubulin inhibitor, ALB 109564(a), were published on the website of the American Society of Clinical Oncology (abstract.asco.org/alb). These results indicate that ALB 109564(a) is well tolerated at the doses tested and shows preliminary evidence of clinical activity in disease types not typically treated with approved vinca alkaloids.
Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Montana Foot Clinic Pc 3419 Central Ave, Ste B, Billings, MT 59102-6647 Ph: (406) 245-0888 | Montana Foot Clinic Pc 3419 Central Ave, Ste B, Billings, MT 59102-6647 Ph: (406) 245-0888 |
News Archive
Routine prophylactic drainage offers no benefits to patients undergoing pancreatic resection, say researchers.
Tecomet Inc., a Genstar Capital portfolio company and precision contract manufacturer supporting the medical device and aerospace industries, announced today that it has completed the previously announced acquisition of Symmetry Medical's OEM Solutions business. This acquisition creates the largest orthopedic contract manufacturer in the world with 18 facilities located in five countries on three continents.
The Smart Card Alliance Identity Council will turn its attention to cybersecurity and healthcare identity in the upcoming year, the Council said today, while continuing its work to educate and make identity credentialing recommendations for corporate enterprise, healthcare, state and local governments, and more. The Identity Council also announced new officers and steering committee, and plans to attend the Smart Card Alliance 8th Annual Smart Cards in Government Conference in Washington, DC.
AMRI announced today that on-going results from its Phase I clinical study on its novel tubulin inhibitor, ALB 109564(a), were published on the website of the American Society of Clinical Oncology (abstract.asco.org/alb). These results indicate that ALB 109564(a) is well tolerated at the doses tested and shows preliminary evidence of clinical activity in disease types not typically treated with approved vinca alkaloids.
Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.
› Verified 3 days ago
Yellowstone Foot & Ankle Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1139 N 27th St, Suite B1, Billings, MT 59101 Phone: 406-252-5444 Fax: 406-245-9043 | |
Dr. William C Oreilly, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1690 Rimrock Rd, Suite L, Billings, MT 59102 Phone: 406-256-0077 Fax: 406-294-0967 | |
Zachary Lubek, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1690 Rimrock Rd Ste L, Billings, MT 59102 Phone: 406-256-0077 Fax: 406-256-3069 | |
Mathias H Fettig, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 3419 Central Ave, Ste B, Billings, MT 59102 Phone: 406-245-0888 Fax: 406-245-1322 | |
Dr. Joel Charles Rutherford, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 77 Lily Valley Cir, Billings, MT 59105 Phone: 406-839-8676 | |
Dr. Merrell Kauwe, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1690 Rimrock Rd Ste L, Billings, MT 59102 Phone: 406-256-0077 Fax: 406-256-3069 |